Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA LABS vs ELDER PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    IPCA LABS ELDER PHARMA IPCA LABS/
ELDER PHARMA
 
P/E (TTM) x 47.8 -1.0 - View Chart
P/BV x 5.0 0.1 4,927.5% View Chart
Dividend Yield % 0.3 0.0 -  

Financials

 IPCA LABS   ELDER PHARMA
EQUITY SHARE DATA
    IPCA LABS
Mar-23
ELDER PHARMA
Jun-14
IPCA LABS/
ELDER PHARMA
5-Yr Chart
Click to enlarge
High Rs1,062380 279.4%   
Low Rs768188 408.5%   
Sales per share (Unadj.) Rs243.0489.2 49.7%  
Earnings per share (Unadj.) Rs19.4-3.2 -609.8%  
Cash flow per share (Unadj.) Rs29.714.4 206.1%  
Dividends per share (Unadj.) Rs4.000-  
Avg Dividend yield %0.40-  
Book value per share (Unadj.) Rs230.3376.5 61.2%  
Shares outstanding (eoy) m253.7020.54 1,235.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.80.6 648.7%   
Avg P/E ratio x47.2-89.3 -52.8%  
P/CF ratio (eoy) x30.819.7 156.3%  
Price / Book Value ratio x4.00.8 526.8%  
Dividend payout %20.60-   
Avg Mkt Cap Rs m232,1205,832 3,979.8%   
No. of employees `000NANA-   
Total wages/salary Rs m12,8762,179 590.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m61,64210,048 613.5%  
Other income Rs m1,518257 591.5%   
Total revenues Rs m63,16010,305 612.9%   
Gross profit Rs m9,0332,921 309.3%  
Depreciation Rs m2,616361 724.0%   
Interest Rs m4822,756 17.5%   
Profit before tax Rs m7,45360 12,452.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,534125 2,024.3%   
Profit after tax Rs m4,919-65 -7,532.2%  
Gross profit margin %14.729.1 50.4%  
Effective tax rate %34.0209.1 16.3%   
Net profit margin %8.0-0.6 -1,227.8%  
BALANCE SHEET DATA
Current assets Rs m51,8939,240 561.6%   
Current liabilities Rs m18,0589,998 180.6%   
Net working cap to sales %54.9-7.5 -727.9%  
Current ratio x2.90.9 310.9%  
Inventory Days Days51128 39.9%  
Debtors Days Days6602 1.0%  
Net fixed assets Rs m34,33613,642 251.7%   
Share capital Rs m254206 123.4%   
"Free" reserves Rs m58,1677,528 772.7%   
Net worth Rs m58,4207,733 755.4%   
Long term debt Rs m6,5184,889 133.3%   
Total assets Rs m86,22922,882 376.8%  
Interest coverage x16.51.0 1,611.6%   
Debt to equity ratio x0.10.6 17.6%  
Sales to assets ratio x0.70.4 162.8%   
Return on assets %6.311.8 53.3%  
Return on equity %8.4-0.8 -997.1%  
Return on capital %12.222.3 54.8%  
Exports to sales %42.93.1 1,405.4%   
Imports to sales %13.30.4 3,092.5%   
Exports (fob) Rs m26,434307 8,622.0%   
Imports (cif) Rs m8,17843 18,973.3%   
Fx inflow Rs m26,434307 8,622.0%   
Fx outflow Rs m8,178125 6,527.9%   
Net fx Rs m18,257181 10,068.8%   
CASH FLOW
From Operations Rs m8,05811,754 68.6%  
From Investments Rs m-7,250-561 1,293.4%  
From Financial Activity Rs m5,072-6,762 -75.0%  
Net Cashflow Rs m5,8815,466 107.6%  

Share Holding

Indian Promoters % 46.3 25.3 182.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 44.8 24.0 186.8%  
FIIs % 10.3 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 53.7 74.7 71.9%  
Shareholders   82,809 31,548 262.5%  
Pledged promoter(s) holding % 0.0 77.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare IPCA LABS With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on IPCA Labs vs Elder Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

IPCA Labs vs Elder Pharma Share Price Performance

Period IPCA Labs Elder Pharma S&P BSE HEALTHCARE
1-Day -1.77% 4.97% -0.98%
1-Month -6.66% 21.21% -5.03%
1-Year 46.64% -64.54% 57.45%
3-Year CAGR 7.56% -51.65% 18.14%
5-Year CAGR 20.01% -37.46% 18.88%

* Compound Annual Growth Rate

Here are more details on the IPCA Labs share price and the Elder Pharma share price.

Moving on to shareholding structures...

The promoters of IPCA Labs hold a 46.3% stake in the company. In case of Elder Pharma the stake stands at 25.3%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IPCA Labs and the shareholding pattern of Elder Pharma.

Finally, a word on dividends...

In the most recent financial year, IPCA Labs paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 20.6%.

Elder Pharma paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of IPCA Labs, and the dividend history of Elder Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Trades Lower | Metal & PSB Stocks Shine | TCS, Apollo Tyre Drop 3% Sensex Today Trades Lower | Metal & PSB Stocks Shine | TCS, Apollo Tyre Drop 3%(10:30 am)

Asian shares slipped before a Bank of Japan policy decision where authorities are likely to bring an end to the world's last negative rates regime.